Board Committees

Audit Committee

  • Appoints our independent auditors.
  • Reviews the quarterly and annual financial statements and audit results and reports, including management comments and recommendations.
  • Reviews the results and scope of audits and other services provided by our independent auditors.
  • Reviews accounting and internal control procedures and policies.
  • Reviews risk exposure of actual or threatened litigation.
  • Reviews significant accounting policies, estimates, audit adjustments and other matters as required.
  • Reviews the audit efforts of our independent auditors and internal audit department.
  • Reviews and approves any non-audit services by our independent auditors in accordance with our Audit and Non-Audit Services Policy.
  • Reviews complaints regarding accounting, internal controls or auditing matters.

Committee Members

Chair

Daniel G. Kaye

Members

Kathryn Benesh
Elizabeth A. Cook
Larry G. Gerdes
Deborah J. Lucas
Terry L. Savage
Dennis A. Suskind

Clearing House Oversight Committee

Provides oversight of the risk management activities (excluding operational risk) of the Clearing House, including oversight of management of the Clearing House with respect to the effectiveness of the risk management program.

Committee Members

Chair

Howard J. Siegel

Members

Michael G. Dennis
Bryan T. Durkin
Martin J. Gepsman
William W. Hobert
Deborah J. Lucas
Patrick J. Mulchrone
William R. Shepard
Robert J. Tierney Jr.

Clearing House Risk Committee

The Clearing House Risk Committee has been established by the Board of Directors of Chicago Mercantile Exchange Inc. as a special committee with participation from market participants. The purpose of the Committee is to assist the Board and the Clearing House Oversight Committee in fulfilling their oversight responsibilities over the risk management (excluding operational risk), financial surveillance, clearing member admission and investigation functions of the Clearing House, other than those relating to interest rate swaps.

The identity of the members of the Committee, other than the Co-Chairs who are members of the CME Board, is confidential.

Committee Members

Chair

William W. Hobert
William R. Shepard

Compensation Committee

  • Recommends and approves compensation arrangements for executive officers and oversees matters relating to employee compensation, employee benefit plans and employee incentive programs.
  • Recommends compensation arrangements for members of the Board.

Committee Members

Chair

Charles P. Carey

Members

Timothy S. Bitsberger
Elizabeth A. Cook
Daniel R. Glickman
Terry L. Savage
Rahael Seifu

Executive Committee

Exercises the authority of the Board when the Board is not in session, except in cases where action of the entire Board is required by our charter, bylaws or applicable law.

Committee Members

Chair

Terrence A. Duffy

Members

Timothy S. Bitsberger
Charles P. Carey
Larry G. Gerdes

Daniel R. Glickman
Daniel G. Kaye
Phyllis M. Lockett
Howard J. Siegel

Dennis A. Suskind

Finance Committee

Reviews and makes recommendations to the Board regarding financial policies, strategies and capital structure.

Committee Members

Chair

Larry G. Gerdes

Members

Timothy S. Bitsberger
Charles P. Carey
Michael G. Dennis
Harold Ford Jr.
Deborah J. Lucas

Patrick J. Mulchrone

IRS Risk Committee

The Interest Rate Swaps Risk Committee has been established by the Board of Directors of Chicago Mercantile Exchange Inc. as a special committee with participation from market participants. The purpose of the Committee is to assist the Board and the Clearing House Oversight Committee in fulfilling their oversight responsibilities over the risk management (excluding operational risk), financial surveillance, clearing member admission and investigation functions of the Clearing House as they relate to interest rate swaps Products (as defined in Chapter 8G of the CME Rulebook).

The identity of the members of the Committee, other than the Chair and the other individual who is a member of the CME Board, is confidential.

Committee Members

Chair

William W. Hobert

Member

William R. Shepard

Market Regulation Oversight Committee

Provides independent oversight of the policies and programs of our Market Regulation Department to ensure effective administration of the Exchange's self-regulatory responsibilities.

Committee Members

Chair

Timothy S. Bitsberger

Members

Kathryn Benesh
Deborah J. Lucas
Rahael Seifu
Dennis A. Suskind

Nominating and Governance Committee

The primary purposes of the Committee are to (i) identify individuals qualified to become directors elected by the holders of the Class A and Class B common stock voting together as a group (each an “Equity Director”) consistent with the criteria established by the Board, and to recommend such nominees for election; (ii) oversee the Company’s policies, procedures and practices in the area of corporate governance, including its Corporate Governance Principles; (iii) recommend and oversee the evaluation process utilized by the Board to evaluate its performance as well as the performance of its committees and individual directors; and (iv) oversee succession planning for the Company’s senior management, including its Chairman and Chief Executive Officer.

Committee Members

Chair

Phyllis M. Lockett

Members

Charles P. Carey
Martin J. Gepsman
Larry G. Gerdes
Daniel R. Glickman
Dennis A. Suskind
Robert J. Tierney Jr.

Risk Committee

The primary purpose of the Committee is to review, assess and provide oversight of the Company’s risk management practices, the integrity and adequacy of its enterprise risk management (“ERM”) Program and the Compliance and Ethics (“C&E”) Program and to assist the Board in its oversight of the effectiveness of the Company’s policies and processes to identify, manage and plan for its operational, strategic, financial and regulatory and compliance risks under its ERM Program and C&E Program.

Committee Members

Chair

Dennis A. Suskind

Members

Timothy S. Bitsberger
Bryan T. Durkin
Daniel G. Kaye
Phyllis M. Lockett
Patrick W. Maloney
William R. Shepard
Howard J. Siegel

Investor Relations Stock Section

CME Stock Chart

CME Group is listed on the NASDAQ under the symbol "CME."

Stock Price (NASDAQ:CME)

$---.--

Change

--- (-%)

High

$---.--

Low

$---.--

Volume

-,---,---

as of ET. Quotes delayed at least 20 minutes.

Contacts

CME Group Shareholder Relations is available to answer administrative questions regarding your common Class A shares. You may contact via phone, email or mail:

Phone: +1 312 930 3484
Email: shareholder.relations@cmegroup.com

Mail:
CME Group Inc.
Shareholder Relations
20 South Wacker Drive
Chicago, IL 60606

For dividend payment information, direct deposit of dividends, address changes and other general inquiries, please contact our transfer agent, Computershare Investor Services.

Class B shareholders should contact the following:  

For confirmation statements, contact CME Group Membership Services Team
Phone: +1 312 435 3480
Email: Seatmarket@cmegroup.com

For questions including administrative questions regarding your CME Group Class B shares, contact CME Group Concierge Team
Phone: +1 312 435 3555
Email: Conciergeteam@cmegroup.com

For questions regarding voting at the CME Group annual meeting, including proxy materials and voting your Class B shares, email Annualmeeting@cmegroup.com.

Mail:
CME Group Inc.
Membership Services
20 South Wacker Drive
Chicago, IL 60606

Institutional investors should contact the CME Group Investor Relations Department. You may contact via phone, email or mail:

Phone: +1 312 466 7459
Email: investors@cmegroup.com

Mail:
CME Group Inc.
Investor Relations
20 South Wacker Drive
Chicago, IL 60606

CME Group is the world’s leading derivatives marketplace. The company is comprised of four Designated Contract Markets (DCMs). 
Further information on each exchange's rules and product listings can be found by clicking on the links to CME, CBOT, NYMEX and COMEX.

© 2024 CME Group Inc. All rights reserved.